共 30 条
- [24] Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease Orphanet Journal of Rare Diseases, 12
- [25] Critical appraisal of arguments for the delayed-start design proposed as alternative to the parallel-group randomized clinical trial design in the field of rare disease ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
- [26] A roadmap to using historical controls in clinical trials – by Drug Information Association Adaptive Design Scientific Working Group (DIA-ADSWG) Orphanet Journal of Rare Diseases, 15